Pricing Log in Create free account

Structure Therapeutics Inc. Sponsored ADR (GPCR) vs Precigen, Inc. (PGEN)

Structure Therapeutics Inc. Sponsored ADR and Precigen, Inc. are both Biotechnology companies. Precigen, Inc. is the larger, with a market value of $1.7B against $1.5B — 1.1× the size. Structure Therapeutics Inc. Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Precigen, Inc. trades at 63.8×. Precigen, Inc. has the higher net margin (15.6% vs 0.00%) and the higher return on invested capital (15.9% vs 0.00%). Across the 14 metrics below, Precigen, Inc. leads on 9 and Structure Therapeutics Inc. Sponsored ADR on 5.

Valuation

Metric GPCR PGEN Biotechnology median
P/E n/m 63.81 11.58
P/S n/m 10.71 9.61
P/B 1.25 20.05 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m 45.87 0.72
EV/Sales n/m 11.10 9.43
Earnings yield (19.04%) 1.57% (32.28%)
Free cash flow yield (18.23%) (4.42%) (22.27%)

Profitability

Metric GPCR PGEN Biotechnology median
Gross margin 0.00% 91.42% 68.81%
Operating margin 0.00% 21.43% 0.00%
Net margin 0.00% 15.55% 0.00%
Free cash flow margin 0.00% (47.35%) 0.00%
Return on equity (29.51%) 38.84% (50.30%)
Return on assets (27.13%) 12.73% (45.47%)
Return on invested capital 0.00% 15.93% 0.00%

Growth

Metric GPCR PGEN Biotechnology median
Revenue growth (TTM) — 2,387.61% 6.78%
EPS growth (last fiscal year) (2.47%) (191.49%) 29.88%
Revenue growth, 5-year CAGR — (21.26%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GPCR PGEN Biotechnology median
Debt to equity 0.00 1.12 0.00
Current ratio 11.91 5.58 4.74
Net debt to EBITDA 8.27 0.04 1.01

Dividend

Metric GPCR PGEN Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric GPCR PGEN Biotechnology median
Market cap 1.49b 1.69b 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack